Levetiracetam for stiff-person syndrome: report of 2 patients
Shimberg, WR, NB Patel, KL Sullivan, RA Hauser, and TA Zesiewicz. 2008. “Levetiracetam for Stiff-Person Syndrome: Report of 2 Patients”. Clin Neuropharmacol.
Search
Search results
751 results found
Optimizing bioavailability in the treatment of Parkinson’s disease.
Seeberger, LC, and RA Hauser. 2007. “Optimizing Bioavailability in the Treatment of Parkinson’s Disease.”. Neuropharmacology.
Social Security Disability Insurance (SSDI) in Parkinson’s disease.
Zesiewicz, TA, A Patel-Larson, RA Hauser, and KL Sullivan. 2007. “Social Security Disability Insurance (SSDI) in Parkinson’s Disease.”. Disabil Rehabil.
Levodopa-induced dyskinesia in Parkinson’s disease: epidemiology, etiology, and treatment.
Zesiewicz, TA, CL Ward, RA Hauser, JL Salemi, S Siraj, MC Wilson, and KL Sullivan. 2007. “Levodopa-Induced Dyskinesia in Parkinson’s Disease: Epidemiology, Etiology, and Treatment.”. Curr Neurol Neurosci Rep .
Open-label pilot study of levetiracetam (Keppra) for the treatment of levodopa-induced dyskinesias in Parkinson’s disease. Movement Disorders 2005;20:1205-1209.
Zesiewicz, TA, KL Sullivan, JL Maldonado, and RA Hauser. 2005. “Open-Label Pilot Study of Levetiracetam (Keppra) for the Treatment of Levodopa-Induced Dyskinesias in Parkinson’s Disease. Movement Disorders 2005;20:1205-1209.”. Movement Disorders.
Levodopa response in early Parkinson’s disease
Hauser, RA, P Auinger, and D Oakes. 2009. “Levodopa Response in Early Parkinson’s Disease”. Mov Disord.
Delayed thalamic intracranial hemorrhage in an essential tremor patient following deep brain stimulation
Zesiewicz, TA, KL Sullivan, M Hoffman, LM Benes, DA Smith, CL Ward, and RA Hauser. 2008. “Delayed Thalamic Intracranial Hemorrhage in an Essential Tremor Patient Following Deep Brain Stimulation”. Eur Neurol.
Ropinirole for Restless Legs Syndrome: A Placebo-Controlled Crossover Trial. Neurology 2004;62:1405-1407.
Adler, CH, RA Hauser, K Sethi, JN Caviness, L Marlor, M Anderson, and JG Hentz. 2004. “Ropinirole for Restless Legs Syndrome: A Placebo-Controlled Crossover Trial. Neurology 2004;62:1405-1407.”. Neurology.
Translocation breakpoint in two unrelated Tourette syndrome cases, within a region previously linked to the disorder. Hum Genet 2003;113:154-161.
Crawford, FC, G Ait-Ghezala, M Morris, MJ Sutcliffe, RA Hauser, AA Silver, and MJ Mullan. 2003. “Translocation Breakpoint in Two Unrelated Tourette Syndrome Cases, Within a Region Previously Linked to the Disorder. Hum Genet 2003;113:154-161.”. Hum Genet.
Clozapine withdrawal symptoms in a Parkinson’s disease patient. Movement Disorders 2002;17:1365-1367.
Zesiewicz, TA, S Borra, and RA Hauser. 2002. “Clozapine Withdrawal Symptoms in a Parkinson’s Disease Patient. Movement Disorders 2002;17:1365-1367.”. Movement Disorders.